This company has been marked as potentially delisted and may not be actively trading. NYSE:PRX Pharmaceutical Resources (PRX) Stock Price, News & Analysis Add Share Share Stock Analysis Stock AnalysisBuy This Stock About Pharmaceutical Resources Stock (NYSE:PRX) 30 days 90 days 365 days Advanced Chart Get PRX alerts:Sign Up Key Stats Today's Range N/A50-Day Range N/A52-Week Range N/AVolume277,372 shsAverage VolumeN/AMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company OverviewPar Pharmaceutical Companies, Inc. is a holding company that, principally through its wholly owned operating subsidiary, Par Pharmaceutical, Inc., is in the business of developing, licensing, manufacturing, marketing and distributing generic and branded drugs in the United States. The Company operates primarily in the United States as two business segments: Par Pharmaceutical (Par), its generic products division, and Strativa Pharmaceuticals (Strativa), its branded products division. In February 17, 2012, the Company acquired Edict Pharmaceuticals Private Limited. On November 17, 2011, it acquired Anchen Incorporated and its subsidiary, Anchen Pharmaceuticals, Inc. In October 2011, it acquired rights to three products from Teva Pharmaceuticals in connection with Teva's acquisition of Cephalon. In September 2012, certain affiliates of TPG acquired the Company.Read More… Receive PRX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Pharmaceutical Resources and its competitors with MarketBeat's FREE daily newsletter. Email Address PRX Stock News HeadlinesProtalix BioTherapeutics targets phase 2 launch for PRX-115 in H2 2025May 10, 2025 | msn.comASX Small Caps Lunch Wrap: Local benchmarks take cue from Wall StreetOctober 13, 2024 | msn.comTrump Makes Major Crypto AnnouncementYou Won’t Get a Second Chance at This Entry The crypto comeback isn't coming—it's already here. And one particular coin is sitting right at the center of this shift.May 28, 2025 | Crypto 101 Media (Ad)NRx Pharmaceuticals, Inc. (NRXP) Q2 2024 Earnings Call TranscriptAugust 15, 2024 | seekingalpha.comCRPGF China Resources Pharmaceutical Group LimitedAugust 14, 2024 | seekingalpha.comAcurx Pharmaceuticals, Inc. (ACXP) Q2 2024 Earnings Call TranscriptAugust 9, 2024 | seekingalpha.comRecursion Pharmaceuticals, Inc. (RXRX) Q2 2024 Earnings Call TranscriptAugust 9, 2024 | seekingalpha.comLexicon Pharmaceuticals Needs To See Real Revenue Acceleration And Clinical/Regulatory SuccessAugust 3, 2024 | seekingalpha.comSee More Headlines PRX Stock Analysis - Frequently Asked Questions What other stocks do shareholders of Pharmaceutical Resources own? Based on aggregate information from My MarketBeat watchlists, some other companies that Pharmaceutical Resources investors own include Gol Linhas Aéreas Inteligentes (GOL), Inovio Pharmaceuticals (INO), NIO (NIO), Nkarta (NKTX), Riot Platforms (RIOT), WildHorse Resource Development (WRD) and C3.ai (AI). Industry, Sector and Symbol Stock ExchangeNYSE SectorN/A Industry N/A Sub-IndustryN/A Current SymbolNYSE:PRX CIK878088 Webwww.parpharm.com Phone+1-845-5735500FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A 10 "Recession Proof" Stocks That Will Thrive in Any MarketWhich stocks are likely to thrive in today's challenging market? Enter your email address and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.Get This Free Report This page (NYSE:PRX) was last updated on 5/28/2025 by MarketBeat.com Staff From Our PartnersJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredF1 Engineering Powers This Electric Marine MotorThe future of marine propulsion has arrived - powered by F-1 grade engineering. In collaboration with McLar...The Tomorrow Investor | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredThe biggest threat isn’t ChinaWhile the headlines focus on AI models and chip speed, Elon Musk is investing in the material side of the stor...True Market Insiders | SponsoredTrump Predicts Dollar DownfallREAD THIS VERY CAREFULLY: If you have $100,000 or more saved for retirement, this may make you VERY angry... ...Augusta Precious Metals | SponsoredThink NVDA’s run was epic? You ain’t seen nothin’ yetAsk most investors and they’ll probably tell you Nvidia is the undisputed AI stock of the decade. In 2023, ...Timothy Sykes | SponsoredThe trade war twist nobody saw comingThe media and financial pundits are all misreading Trump’s actions. They think Trump wants to make Canada t...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Pharmaceutical Resources Please log in to your account or sign up in order to add this asset to your watchlist. Share Pharmaceutical Resources With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.